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Purpose: Venous thrombosis i associated with a significant inflammatory response, which 
can be visualized by gadolinium magnetic resonance venography (MRV). Gadolinium 
extravasates into tissue during inflammation, producing perithrombus enhancement on 
magnetic resonance scanning. This study determines (1) whether gadolinium enhance- 
ment occurs during deep venous thrombosis (DVT); and (2) whether this enhancement 
changes with time and can therefore stablish the age of  thrombus. 
Methods: Patients with a diagnosis of  iliofemoral DVT by duplex ultrasound who were 
referred for MRV to document central thrombus extent were studied. T1 weighted 
images were obtained before and after gadolinium injection (0.1 mmol/kg);  repeat scans 
were obtained up to 3 months thereafter. At the level of  maximum thrombus, measure- 
ments of  signal intensity were made at the periphery (rim), and the center of  the 
thrombosed vein, as well as the contralateral normal vein, on images after gadolinium 
enhancement. Rim-center vein signal intensity ratios were then calculated and followed. 
Results: A total of  39 scans were obtained in 14 patients (eight men, six women). The 
thrombosed veins were enlarged, with a peripheral rim of  enhancement ("bull's-eye" 
sign). The rim-center ratio for thrombosed veins (2.16 -+ 0.18) was different from that of  
normal veins (0.66 -+ 0.10; n = 39; p < 0.001). For all acute studies (-----14 days) the 
rim-center ratio was 2.38 + 0.17 (n = 31), whereas for all chronic studies (> 14 days) the 
rim-center ratio was 1.29 -+ 0.44 (n = 8; p = 0.001). Among patients who underwent 
both early and late studies, the rim-center ratio dropped significantly, from 2.33 -+ 0.20 
acutely to 1.29 -+ 0.44 in chronic studies (n = 8; p = 0.03). One patient with active 
malignancy had a paradoxic increase in rim-center ratio over time and a clinical recurrence 
of symptoms, suggesting active thrombosis. 
Conclusions: We conclude that (1) a pattern of  peripheral gadolinium enhancement 
(bull's-eye sign) is seen around acutely thrombosed veins on gadolinium-enhanced MRV, 
facilitating DVT diagnosis; and (2) the ratio of  signal intensity at the rim versus the 
center of  the thrombosed vein may be a good discriminator of  acute compared with 
chronic DVT, which may help direct therapy. (J Vasc Surg 1997;26:809-16.) 
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Venous thrombosis and resultant pulmonary em- 
bolism is the most common preventable cause of  
hospital death. It is estimated that as many as 
150,000 to 200,000 people die each year o f  compli- 
cations related to thromboembol ism. 1 Because o f  
this prevalence, much work has been focused on the 
diagnosis and treatment o f  deep venous thrombosis 
(DVT). Improved accuracy, as well as low risk and 
low cost, have made duplex ultrasound the standard 
test for the presence of  venous thrombosis. It  has an 
estimated sensitivity and specificity that exceed 
95%. 1,2 Nonetheless, this method has limitations. 
Duplex ultrasound is not  reliable in diagnosing iliac 
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Table I. Patient data 
MRI 
day after diagnosis 
A•e 
Patient (yr) Sex Symptoms Diagnosis Treatment 1 3 5 7 14 21 30 90 
1 64 M Rt. LE edema, 2-3 days Trauma Heparin and warfarin X 
2 57 M Rt. LE edema, 1 day S/P femoropopliteal bypass Heparin and warfarin X X 
grafting 
3 59 F Not recorded U~S/P  laparotomy Not recorded X X X 
4 54 M Rt. LE edema <1 week Pulmonary HTN/renal cell Heparin and warfarin X X X 
carcinoma 
5 89 M Acute SOB, no edema Prostate cancer Heparin and warfarin X 
6 57 M Lt. LE edema, × 7 days DVT Heparin and warfarin X 
7 72 F Lt. LE edema, pain, S/P PTA Heparin and warfarin X X X X 
acute SOB < i day 
8 30 M Lt. LE edema, × 2 days Paraplegia Heparin and warfarin X X X 
9 55 F Rt. LE edema; DM; norcardia; foot ulcers Heparin and warfarin X X X 
tenderness, × 1 week 
10 68 F Rt. LE edema, × 3 days AAA Heparin and warfarin X X X 
11 66 F Lt. LE pain, edema × 2 Ovarian cancer Heparin and warfarin X X 
days 
12 60 F Lt. LE edema, pain < 1 Raynaud's disease Heparin and warfarin X 
day 
13 43 M Lt. LEedema,<lweek  CRF, DM Heparin and warfarin X X X X 
14 67 M Lt. LE edema, pain × 3 HTN, AF, S/P Heparin and warfarin X X X 
days ureteroscopy 
X 
LE, Lower extremity; SOB, shortness of breath; S/P, status post; UC, ulcerative colitis; HTN, hypertension; PTA, percutaneous 
transluminal ngioplasty; DM, diabetes mellitus; AAA, abdominal aortic aneurysm; CRF, chronic renal failure; AF, atrial fibrillation. 
thrombosis because of difficulties in imaging above 
the inguinal igament. Furthermore, criteria used for 
estimating the age of a venous thrombus by ultra- 
sound are often not reliable. Therefore, identifying 
both the proximal extent and the age of some 
thrombi requires further testing. This is not an un- 
common experience, as a history of previous DVT is 
among the most important risk factors for acute 
DVT. 
Acute DVT elicits a strong inflammatory re- 
sponse in the vein wall and surrounding tissue at the 
site of  the venous thrombus, characterized by an 
initial neutrophil nfiltration followed by a monocyte 
macrophage xtravasation i to the vein wall. a-6 In- 
flammation appears to bc mediated by cytoldnes and 
adhesion moleculesA This inflammation may not 
only contribute to symptoms, but may also play a 
role in the pathogenesis of ongoing thrombosis. 
Magnetic resonance imaging (MRI,) studies of exper- 
imentally induced thrombosis n animals uggest that 
the enhancement seen with gadolinium infusion cor- 
rcsponds to thc areas of  increased inflammation seen 
pathologically. Over time, the inflammation sub- 
sides. This suggests that the presence of vein wall and 
perivenous inflammation may discriminate acute 
from chronic DVT. 
The purpose of this study was to identify how 
gadolinium-enhanced magnetic resonance venogra- 
phy (MRV) images change as acute DVT progresses 
to chronic DVT. It is our hypothesis that gadolinium 
enhancement may identify acutely thrombosed veins 
(with active inflammation) in clinical DVT and dif- 
ferentiate them from chronically thrombosed veins 
(without active inflammation). This may provide a 
mechanism for determination of thrombus age, a 
means for the diagnosis of acute DVT in the setting 
of a history of chronic venous thrombosis, and pro- 
vide a method for evaluating the inflammatory re- 
sponse to venous thrombosis and interventions in- 
tended to modify this response. 
i~TERIALS AND METHODS 
Patients greater than 18 years of age of either sex 
who were found on noninvasive testing in the Diag- 
nostic Vascular Laboratory at the University of 
Michigan Medical Center to have significant iliofem- 
oral vein thrombus were invited to participate in the 
study. Patients with iliac vein involvement were in- 
cluded selectively to focus on patients with thrombus 
in the same vein segment, and also because they had 
a clinical indication for the initial MRV study: to 
determine the central extent of thrombus. Only 
those patients in whom the proximal extent of 
thrombus could not be imaged with ultrasound were 
included. Subjects were excluded if they were un- 
willing or unable to undergo MRI scanning, (e.g., 
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Fig. 1. Note enhancement onimage after gadolinium injection (left) compared with inversion 
recovery image (right). Enhancement with gadolinium was limited to vein wall, whereas edema 
(bright signal on inversion recovery) involved vein wall and perivenous tissue. 
claustrophobia), if there was a contraindication to
scanning (e.g., pacemaker), if they were immunosup- 
pressed or immunocompromised for some reason, or 
if the thrombus was seen in its entirety and there was 
no question of central thrombus extent. 
The study patients underwent an initial MRV 
study within 24 hours of diagnosis, followed by re- 
peat scans on days 3, 5, 7, and 14 after diagnosis, as 
permitted by the patient's clinical status and care. 
Follow-up scans were obtained on an outpatient ba- 
sis 3 months after diagnosis. Scans were performed 
with a 1.5 Tesla magnet (GE Medical Systems, Signa, 
Milwaukee). Time of flight, inversion recovery, T1, 
and T2 weighted images were obtained, as well as 
repeat T1 weighted images with fat saturation after 
intravenous infusion of gadopentetate dimeglumine 
(gadolinium) (0.1 mmol/kg,  Berlex Laboratories, 
Wayne, N.J.). At the level of maximal clot involve- 
ment in the iliac vein, the diameters of the involved 
and contralateral uninvolved iliac veins were mea- 
sured. The signal intensity was measured at the pe- 
riphery (rim) and at the center of both the throm- 
bosed and contralateral nonthrombosed veins, and a 
ratio of rim-to-center signal intensity was calculated 
for each of the vessels. These data were then plotted 
and analyzed over time both in aggregate and for 
individual subjects. 
Statistical analysis was carried out using Mann- 
Whitney rank-sum, paired and nonpaired, nonpara- 
metric t tests for nonnormal distribution values, and 
paired and nonpaired Student's t test for the data 
that passed tests for normality. Values are indicated 
as mean -+ the standard error of the mean. Tests used 
were two-tailed. A piecewise linear regression analy- 
sis was performed to determine whether there was a 
time-dependent breal;point in the data. Informed 
consent was obtained from all of the study partici- 
pants, and both the protocol and consent form were 
approved by the Institutional Review Board for Hu- 
man Study of the Universit T of Michigan Medical 
Center (protocol #IRB 94-544). 
RESULTS 
A total of 39 MRV scans were obtained in 14 
patients, eight men and six women. This was less 
than the protocol called for, as a result of poor 
compliance, inability to successfully complete scans, 
and patient drop-out because of  underlying medical 
problems. The patients' ages ranged from 30 to 89 
years, with a mean of 60 years. Of  the 14 patients, 
three had underlying malignancy, four had periph- 
eral arterial occlusive disease, two had had traumatic 
injuries, and four had recently undergone surgery or 
invasive procedures (Table I). Only one patient had 
no identifiable underlying medical problem or risk 
factor for DVT. 
On images obtained after gadolinium enhance- 
ment, all of the thrombosed veins were enlarged 
compared with the contralateral normal vein. The 
average diameter of the thrombosed veins was signif- 
icantly greater than the nonthrombosed normal-side 
veins (16.3 + 0.84 mm vs 13.5 + 0.55 mm, respec- 
tively; p = 0.01). Images of thrombosed veins dem- 
onstrated bright signal on inversion recovery se- 
quences, as well as enhancement of the thrombosed 
vein wall and perivenous tissue on images after gad- 
olinium enhancement. The gadolinium enhance- 
ment was more intense in the vessel wall than the 
bright signal noted on inversion recovery images 
(Fig. 1). Gadolinium enhancement was greatest 
where thrombus was in contact with the v ssel wall. 
In acutely thrombosed veins in which a flow channel 
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Big. 2. Enhancement after gadolinium injection (right) occurred where thrombus was adher- 
ent to vein wall, whereas less enhancement was seen where flow channel was present on 
time-of-flight imaging (left). 
remained patent, enhancement was not noted in the 
area of the patent flow channel but only in the area of  
the adherent thrombus (Fig._2). 
Analysis of the imaged veins was made by calcu- 
lating the ratio of the measured intensity at the rim of  
the vessel and dividing by the intensity at the center 
of the vessel on gadolinium-enhanced images. This 
rim-center atio was then compared between the 
thrombosed and nonthrombosed vessels. This ratio 
was 2.16 + 0.18 for all thrombosed veins and 0.66 + 
0.10 for contralateral normal veins (n = 39; p < 
0.001). 
Unlike the bright signal that is noted on inversion 
recovery imaging, the perivenous enhancement after 
gadolinium infusion decreased with time (Fig. 3). 
For studies performed within 14 days of diagnosis, 
the average rim-center ratio for the thrombosed ves- 
sel was 2.38 -+ 0.17 (n = 31) compared with an 
average rim-center ratio of 1.29 --- 0.44 (n = 8) for 
studies performed greater than 14 days from the time 
of diagnosis (p = 0.001). This included one patient 
who had clinical evidence of recurrent hrombosis 
and an elevated rim-center atio on a late study. 
Excluding this patient, the mean rim-center ratio for 
patients studied within 14 days of diagnosis was 
2.34 _+ 0.18 (n = 29), and for those studied greater 
than 14 days from the day of diagnosis 0.85 + 0.11 
(n = 7; p < 0.001). These data were then reanalyzed 
in a paired fashion, comparing studies performed 
within 14 clays after diagnosis with only those studies 
performed in the same patients greater than 14 days 
after diagnosis. There were eight late (> 14 days after 
diagnosis) scans performed in seven patients. These 
values were 2.33 _+ 0.20 vs 1.29 _+ 0.44 for early and 
late scans, respectively (n = 8; p = 0.03). Excluding 
the one patient with late clinical rethrombosis, these 
values are 2.25 + 0.21 and 0.85 + 0.11 (n = 7;p < 
0.001; Table II). 
A piecewise linear regression analysis of the rim- 
center intensity ratios for the thrombosed veins was 
then performed to determine whether there was a 
significant breakpoint in time after which the ratios 
became distinctly different. We first used this model 
to determine linearity of the rim-center data over 
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Fig. 3. Note that gadolinium enhancement that acutely (left) produced characteristic "bull's- 
eye" sign decreased chronically (right). Vein likewise decreased in circumference. T1 weighted 
images after gadolinium enhancement (both right and left). 
Table II. MRI data for DVT patients 
Acute (<-24 days) Chronic (>14 days) p 
All studies 2.38 + 0.17 (n =31) 1.29 -+ 0.44 (n = 8) p = 0.001 
All studies 2.34 + 0.18 (n = 29) 0.85 + 0.11 (n = 7) p < 0.001 
(excluding rethrombosed patient) 
Paired analysis 2.33 + 0.20 (n = 8) 1.29 _+ 0.44 (n = 8) p = 0.03 
Paired analysis 2.25 + 0.21 (n = 7) 0.85 +_ 0.11 (n = 7) p < 0.001 
(excluding rethrombosed patient) 
time. The data were nonlinear, which allowed the 
determination f a critical timepoint that clearly dif- 
ferentiates the data. Excluding the one patient who 
had clinical recurrent thrombosis, there was a break- 
point 14 days after the diagnosis that approached 
statistical significance (n = 38; p = 0.06; Fig. 4). 
DISCUSSION 
Duplex ultrasound has become the preferred i- 
agnostic test for DVT of the lower extremities. This 
method has limitations, however, particularly in dis- 
tinguishing chronic from acute clot. In this prelimi- 
nary study of 14 patients with DVT, we have demon- 
strated a method for using MRV with gadolinium 
enhancement to identify acute iliac vein thromboses 
and to distinguish acute iliac vein thrombus from 
chronic thrombus. Acute thrombosis n the iliac vein 
is accompanied by gadolinium enhancement of the 
vessel wall, which diminishes with time. A ratio of the 
measured signal intensity at the rim versus the center 
of a thrombosed vein appears to be elevated in the 
acute setting, and declines toward or below unity 
with time. This happens approximately 2 weeks (14 
days) after DVT diagnosis. 
MRI diagnosis of DVT has been demonstrated 
previously. Tavares et al. 7 in 1989 described the use 
of magnetic resonance to detect intraluminal clot. 
They studied 66 vessels in 45 patients and docu- 
mented the ability to identify intraluminal clot. They 
reported a sensitivity and specificity of 85% and 90%, 
respectively, with combined phase and magnitude 
spin echo images. Evans et al. 8 reported the results of 
a prospective comparison study between magnetic 
resonance and venography in the diagnosis of acute 
DVT. Using both methods, they imaged 61 consec- 
utive patients suspccted of having acute venous 
thrombosis. They found thrombi in 21 of these pa- 
tients. They reported a sensitivity and specificity of 
100% and 95%, respectively, in the pelvis, 100% and 
100%, respectively, in the thigh, and 87% and 97%, 
respectively, in the calf. Spritzer and colleagues 9 also 
have reported on the use of MRI in the diagnosis of 
acute DVT. They reviewed aprospectively collected 
clinical experience of 199 patients who underwent 
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Fig. 4. Piecewise linear egression analysis with best-fit lines for thrombosed veins over time. 
gradient recalled echo MR/ looldng for acute DVT. 
Of these cases, 79 underwent confirmatory venogra- 
phy, ultrasound, or computed tomography. The sensi- 
tivity and specificity were 97% and 95%, respectively. 
Finally, Carpenter et al. 1° reported acomparison study 
of 85 patients who underwent MR/, venography, and 
duplex ultrasound scanning of the infrarenal venous 
system. The found a sensitivity and specificity for MRI 
of 100% and 96%, respectively. 
Few studies that used MRV have focused on the 
issue of characterizing the thrombus age. In one such 
study, Soler et al. H reported the use of MR/ in 
inferior vena cava thrombosis. They reported the 
results of 30 MR/ examinations in 17 patients in 
whom inferior vena cava thrombosis was suspected. 
Nineteen thrombosed veins were reported, and the 
patients were divided on the basis of the time from 
onset of symptoms. The thrombi were then charac- 
terized on the basis of homogeneity of  signal inten- 
sity within the lumen on Tl-weighted spin-echo 
images. Thrombi were classified as either homoge- 
neous or heterogeneous. Classification of  image 
character was done by two independent observers 
who were blinded to the clinical situation. Six of 
seven acute thrombi were classified as homogeneous 
(86%), and ninc of 12 nonacute thrombi wcre classi- 
fied as heterogeneous (75%; p < 0.01). 
The use of gadolinium as an intravenous contrast 
agent has been reported for the MR/evaluation of 
both arterial and venous tructures. Kaufman et al. 12 
reported the use of gadolinium-enhanced time-of- 
flight three-dimensional reconstructions for the eval- 
uation of  the vena cava and its branches. Revel and 
colleagues 13 also described the use of gadolinium as 
an intravenous contrast agent for the imaging of  the 
vascular anatomy, specifically that in the thorax. Gad- 
olinium chelates decrease the T1 relaxation time, 
which results in enhancement. Gadolinium extrava- 
sates in areas of capillary leak that are related to 
inflammation and will not simply enhance the areas 
of edema.14 This property of gadolinium was used in 
the present study. 
Several studies have documented the ability of 
gadolinium to selectively increase nhancement on 
MRI at sites of inflammation. Paajanen et al) s used 
an animal model of inflammation to document fo- 
cally increased enhancement on MRI after gadolin- 
ium infusion. Subcutaneous injection ofcarragcenan 
in rats caused local inflammation and enhancement 
after gadolinium infusion. They also demonstrated 
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enhancement after gadolinium injection on MRI sur- 
rounding liver abscesses. This enhancement, seen at 
the abscess rim, correlated histologically with the 
presence of  inflammatory cells. I6 Palmer et al.17 de- 
scribed the use of gadolinium-enhanced MRI of the 
wrist in human beings to document and quantify 
joint inflammation. Using gadolinium-enhanced 
MRI and fluorodeoxyglucose positron emission to- 
mographic scanning of the wrist in 12 patients with 
arthritic joint inflammation, they demonstrated that 
enhancement on MRI after gadolinium infusion cor- 
related with fluorodeoxyglucose uptake on positron 
emission tomographic scans, and that both of these 
markers of inflammation were strongly associated 
with clinical findings of  active inflammation in the 
wrists. Others had previously described the use of 
MRI with gadolinium to visualize synovial inflamma- 
tion in rheumatoid arthritis, ls,~9 Chan et al.20 re- 
ported the use of gadolinium-enhanced MRI in a 
chinchilla model of otitis media. They used histamine 
on chinchilla middle ear mucosa nd compared gad- 
olinium enhancement with control animals that were 
pretreated with hydroxyzine (an H1 antagonist), an- 
other control group that was pretreated with raniti- 
dine (an H2 antagonist), and a third control group 
that received both agents. They documented an in- 
crease in gadolinium enhancement after the applica- 
tion of  histamine and an attenuation of this enhance- 
ment in the setting of antihistamines, particularly H1 
antagonists. More recently, Ostergaard et al.2t re- 
ported the use of gadolinium-enhanced MRI in 18 
arthritic knees before, during, and after intraarticular 
steroid therapy. Enhancement of the synovial mem- 
brane was documented on gadolinium-enhanced T1 
weighted magnetic resonance scans before treat- 
ment. This enhancement decreased in all the joints 
imaged within a week of steroid injection. Clinical. 
relapse correlated with a resurgence of synovial en- 
hancement. 
Our interest in this study focused on the impor- 
tance of gadolinium enhancement in the wall and 
perivenous tissue surrounding a thrombosed vein. 
This phenomenon was observed initially in animal 
studies in both a rat model and a primate model of 
venous thrombosis and was used to evaluate the 
efficacy of inflammatory inhibition. 22 In those stud- 
ies, gadolinium-enhanced MRIs were compared with 
pathologic specimens taken at various time points 
after thrombus induction by inferior vena cava occlu- 
sion. 23 Inflammatory changes seen pathologically 
corresponded with both the appearance and location 
of enhancement on MRIs. This inflammatory re- 
sponse in the vein wall and perivenous tissue appears 
to be mediated by proinflammatory c tokines and 
adhesion molecules and may serve as a marker of 
thrombus age. In addition, gadolinium enhance- 
ment corresponded to the location of adherent 
thrombus to the vein wall. In the present study, we 
did find that gadolinium enhancement does occur in 
human DVT as it does in animal models. The mea- 
surement of a rim-center enhancement ratio allowed 
for a determination of acute from chronic thrombo- 
sis. 
This study has several limitations. First, it is small 
and is intended as a preliminary observation only. 
Larger numbers of patients will be needed to confirm 
these findings. A validation study will be needed to 
determine clinical utility. Second, we evaluated only 
patients who had iliofemoral venous thrombi. No 
comment on generalizability can be made until other 
segments are studied. 
CONCLUSION 
MRI after gadolinium infusion demonstrates vein 
wall and perivenous enhanced signal intensity in the 
setting of acute venous thrombosis. This enhance- 
ment results in a characteristic appearance of the 
thrombosed vein with the rim brighter than the cen- 
ter, the so-called "bull's-eye" sign. Gadolinium en- 
hancement fades with time, which presumably re- 
flects organization of the thrombus and a decrease in 
inflammation (capillary leak). This finding may aid in 
the clinical distinction of acute venous thrombosis 
from chronic venous thrombus. Gadolinium en- 
hancement, as a marker of perivenous inflammation, 
may therefore also provide a method for the assess- 
ment of the inflammatory response to acute venous 
thrombosis in different settings and assessment ofthe 
response to antiinflammatory and antithrombotic 
treatment for acute DVT. 
We aclmowledge M. Anthony Schork, PhD, for assis- 
tance with statistical nalysis. 
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